Topical nanoliposomal Amphotericin B Gel

Treatment of cutaneous leishmaniasis Effective in the treatment of topical fungal diseases

Reduction of microbial activity due to drug use Fewer side effects and lower cost than conventional leishmaniasis drugs

This product is 0.4% nanoliposomal amphotericin B topical gel produced for the treatment of cutaneous leishmaniasis and is topically applicable. Amphotericin B is an anti-parasitic and anti-fungal drug; effective for the treatment of cutaneous leishmaniasis. Due to renal toxicity caused by this drug, liposomal formulations can be used for targeted drug delivery. Liposomal formulations reduce the damaging effects of the drug on the body and increase the penetration and transfer to the fungus.